Researcher
Hans Wildiers
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Projects
1 - 10 of 27
- Breast cancer projectFrom1 Jan 2024 → TodayFunding: Other federal public and semi-governmental institutions
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Building a large blood biobank of patients with new breast cancer diagnosis for future researchFrom1 Jan 2022 → 5 Jun 2023Funding: Other federal public and semi-governmental institutions
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- The impact of coaching on quality of life of older cancer patientsFrom27 Sep 2021 → 31 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patientsFrom1 Apr 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Mechanisms involved in metastasis of luminal breast cancerFrom1 Mar 2021 → 28 Feb 2022Funding: Foundations, funds and other with scientific goal
- The MBC biobank collection.From1 Dec 2020 → 31 Oct 2021Funding: Other federal public and semi-governmental institutions
- Risk prediction and modeling of cancer therapy related cardiotoxicityFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Novel biomarkers in the risk stratification, surveillance and treatment of young breast cancer patients and germline carriers of pathogenic variants in TP53.From1 Sep 2020 → 13 Feb 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
311 - 320 of 475
- Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer(2015)
Authors: Patrick Neven, Lynn Jongen, Beppe Floris, Hans Wildiers
Pages: 437 - 438 - Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer(2015)
Authors: Chantal Van Ongeval, Hans Wildiers
Pages: 72 - 75 - Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study(2015)
Authors: Hans Wildiers
Pages: 182 - 190 - A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients(2015)
Authors: Diether Lambrechts, Hans Wildiers
Pages: 978 - Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk(2015)
Authors: Patrick Neven, Els Wauters, Hans Wildiers, Diether Lambrechts
Pages: 285 - 298 - Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy(2015)
Authors: Diether Lambrechts, Sigrid Hatse, Hans Wildiers, Ann Smeets
Pages: 18 - Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy(2015)
Authors: Jieping Lei, Anja Rudolph, Kirsten B Moysich, Sajjad Rafiq, Sabine Behrens, Ellen L Goode, Paul P D Pharoah, Petra Seibold, Peter A Fasching, Irene L Andrulis, et al.
Pages: 18 - Fall predictors in older cancer patients: a multicenter prospective study(2014)
Authors: Cindy Kenis, Pieter Heeren, Johan Flamaing, Hans Wildiers, Koen Milisen
- Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens(2014)
Authors: Anneleen Lintermans, Dirk Vanderschueren, Johan Verhaeghe, Kathleen Van Asten, Annouschka Laenen, Robert Paridaens, Jaak Billen, Steven Pauwels, Pieter Vermeersch, Hans Wildiers, et al.
Pages: 2925 - 2931 - How to Implement a Geriatric Assessment in Your Clinical Practice(2014)
Authors: Hans Wildiers
Pages: 1056 - 1068